Eupraxia Pharmaceuticals Statistics

Total Valuation

TSX:EPRX has a market cap or net worth of CAD 228.72 million. The enterprise value is 232.65 million.

Market Cap	228.72M
Enterprise Value	232.65M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:EPRX has 35.85 million shares outstanding. The number of shares has increased by 37.52% in one year.

Current Share Class	35.85M
Shares Outstanding	35.85M
Shares Change (YoY)	+37.52%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	22.83%
Owned by Institutions (%)	6.22%
Float	24.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.37

Financial Position

The company has a current ratio of 13.00, with a Debt / Equity ratio of 0.00.

Current Ratio	13.00
Quick Ratio	12.59
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-43.00

Financial Efficiency

Return on equity (ROE) is -116.77% and return on invested capital (ROIC) is -62.63%.

Return on Equity (ROE)	-116.77%
Return on Assets (ROA)	-52.06%
Return on Invested Capital (ROIC)	-62.63%
Return on Capital Employed (ROCE)	-101.48%
Revenue Per Employee	n/a
Profits Per Employee	-1.19M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-578
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +105.31% in the last 52 weeks. The beta is 1.43, so TSX:EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	+105.31%
50-Day Moving Average	5.50
200-Day Moving Average	4.70
Relative Strength Index (RSI)	83.59
Average Volume (20 Days)	32,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.43M
Pretax Income	-37.88M
Net Income	-39.19M
EBITDA	-39.26M
EBIT	-39.43M
Earnings Per Share (EPS)	-1.10

Full Income Statement

Balance Sheet

The company has 39.46 million in cash and 75,855 in debt, giving a net cash position of 39.39 million or 1.10 per share.

Cash & Cash Equivalents	39.46M
Total Debt	75,855
Net Cash	39.39M
Net Cash Per Share	1.10
Equity (Book Value)	38.86M
Book Value Per Share	-0.12
Working Capital	37.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.92 million and capital expenditures -383,028, giving a free cash flow of -43.30 million.

Operating Cash Flow	-42.92M
Capital Expenditures	-383,028
Free Cash Flow	-43.30M
FCF Per Share	-1.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.52%
Shareholder Yield	n/a
Earnings Yield	-17.14%
FCF Yield	-18.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1